Sage Journals: Discover world-class research

Abstract

Aim

The aim of this study was to compare the diagnostic performance of whole-body bone scintigraphy (WBS) and multi-field-of-view single photon emission tomography (multi-FOV SPECT) with ^99mTc-oxidronate (^99mTc-HDP) in patients with prostate cancer (PCa).

Methods

In a prospective study, WBS and SPECT acquisitions were performed in194 patients with histologically confirmed PCa and serum prostate-specific antigen (PSA) levels above 10 ng/mL. Scans obtained using the two modalities were interpreted separately. Clinical and biochemical follow-up, radiological studies and biopsies served as benchmarks for the assessments. The impact of PSA level on WBS and SPECT results was also evaluated.

Results

The patient-based sensitivity, specificity, accuracy, PPV and NPV values of SPECT examinations were higher than those of WBS, especially in patients with serum PSA levels ≶40 ng/mL.

Conclusion

Multi-FOV SPECT proved to be more sensitive and specific than WBS in detecting bone metastases in PCa patients.

Keywords

single photon emission tomography bone metastases prostate cancer

Get full access to this article

View all access options for this article.

References

Rigaud

, Tiguert

, Le Normand

, Karam

, Glemain

, Buzelin

J.M.

, Bouchot

: Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy. J Urol, 168: 1423–1426, 2002.

Han

, Partin

A.W.

, Zahurak

, Piantadosi

, Epstein

J.I.

, Walsh

P.C.

: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol, 169: 517–523, 2003.

Kosuda

, Yoshimura

, Aizawa

, Koizumi

, Akaza

, Kuyama

, Ichihara

, Yonese

, Koizumi

, Nakashima

, Fujii

: Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Cancer, 94: 964–972, 2002.

Even-Sapir

, Martin

R.H.

, Barnes

D.C.

, Pringle

C.R.

, Iles

S.E.

, Mitchell

M.J.

: Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology, 187: 193–198, 1993.

Gates

G.F.

: SPECT bone scanning of the spine. Semin Nucl Med, 28: 78–94, 1998.

Nozaki

, Yasuda

, Akashi

, Fuse

: Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer. Int J Urol, 15: 516–519, 2008.

Thurairaja

, McFarlane

, Traill

, Persad

: State-of-the-art approaches to detecting early bone metastasis in prostate cancer. BJU Int, 94: 268–271, 2004.

Sarykaya

, Sarykaya

, Holder

L.E.

: The role of single photon emission computed tomography in bone imaging. Semin Nucl Med, 31: 3–16, 2001.

Even-Sapir

, Metser

, Mishani

, Lievshitz

, Lerman

, Leibovitch

: The detection of bone metastases in patients with high-risk prostate cancer: ^99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med, 47: 287–297, 2006.

10.

Song

, Segars

W.P.

, Du

, Tsui

B.M.

, Frey

E.C.

: Fast modeling of the collimator-detector response in Monte Carlo simulation of SPECT imaging using the angular response function. Phys Med Biol, 21: 1791–1804, 2005.

11.

Schünnemann

, Heidrich

, Sahlmann

C.O.

, Siefker

, Luig

, Werner

, Brunner

, Meller

: Improvement of tomographic reconstruction in bone SPECT. Nuklearmedizin, 45: 35–40, 2006.

12.

Wells

R.G.

, Farncombe

, Chang

, Nicholson

R.E.

: Reducing bladder artefacts in clinical pelvic SPECT images. J Nucl Med, 45: 1309–1314, 2004.

13.

Strobel

, Burger

, Seifert

, Husarik

D.B.

, Soyka

J.D.

, Hany

T.F.

: Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol, 188: 467–474, 2007.

14.

Chybowski

F.M.

, Keller

J.J.

, Bergstralh

E.J.

, Oesterling

J.E.

: Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol, 145: 313–318, 1991.

15.

Ghanem

, Uhl

, Brink

, Schäfer

, Kelly

, Moser

, Langer

: Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol, 55: 41–55, 2005.

16.

Bouchelouche

, Oehr

: Recent developments in urologic oncology: positron emission tomography molecular imaging. Curr Opin Oncol, 20: 321–326, 2008.

17.

Gemmel

FFAY

: Magnetic resonance imaging versus bone scan in high-risk prostatic carcinoma: some methodological considerations. J Clin Oncol, 26: 1189–1190, 2008.

Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer